Literature DB >> 30359939

The Mindfulness-Based Interventions: Teaching Assessment Criteria (MBI:TAC): reflections on implementation and development.

Rebecca S Crane1, Willem Kuyken2.   

Abstract

The Mindfulness-Based Interventions: Teaching Assessment Criteria (MBI:TAC) is a tool for supporting good practice in mindfulness-based teaching, training supervision and research contexts. It has been taken up in practice in teacher training organizations worldwide. The MBI:TAC sits within the wider consideration within research contexts of building methodological rigor by developing robust systems for ensuring intervention integrity. Research on the tool is at an early stage and needs development. The process of implementation needs careful attention to ensure reliability and good practice. Future research is needed on the tool's reliability, validity and sensitivity to change, and on the relationships between mindfulness-based teaching, participant outcomes and key contextual factors, including the influence of participant population, culture and context.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30359939     DOI: 10.1016/j.copsyc.2018.10.004

Source DB:  PubMed          Journal:  Curr Opin Psychol        ISSN: 2352-250X


  3 in total

1.  Living the Full Catastrophe: A Mindfulness-Based Program to Support Recovery from Stroke.

Authors:  Lori A Gray
Journal:  Healthcare (Basel)       Date:  2020-11-19

2.  Mindfulness and Behavior Change.

Authors:  Zev Schuman-Olivier; Marcelo Trombka; David A Lovas; Judson A Brewer; David R Vago; Richa Gawande; Julie P Dunne; Sara W Lazar; Eric B Loucks; Carl Fulwiler
Journal:  Harv Rev Psychiatry       Date:  2020 Nov/Dec       Impact factor: 3.732

3.  Mindfulness-based cognitive therapy experiences in youth with inflammatory bowel disease and depression: findings from a mixed methods qualitative study.

Authors:  Tatjana Ewais; Jake Begun; Maura Kenny; Alan Headey; Merilyn Tefay; Steve Kisely
Journal:  BMJ Open       Date:  2020-11-04       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.